The FDA has even approved a drug manufactured with cannabidiol for that goal (Epidiolex). Even so the agency only endorses it for two scarce kinds of childhood epilepsy identified as Lennox-Gastaut syndrome and Dravet syndrome. Two oral THC-containing medicine — nabilone and dronabinol — have been accessible for the therapy https://beckettwflfy.blogminds.com/the-definitive-guide-to-psychoactive-cannabinoids-32071099